The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPEMV.L Regulatory News (PEMV)

  • There is currently no data for PEMV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

29 Nov 2013 10:22

RNS Number : 2784U
Pembroke VCT PLC
29 November 2013
 

Pembroke VCT plc

HALF-YEARLY REPORT

for the period ended 30 September 2013

 

 

OVERVIEW

 

Investment Objective

Pembroke VCT plc (the "Company") is a generalist VCT focused on private equity style investments in the leisure and luxury brands sectors. The Company will seek to invest in a diversified portfolio of small, principally unquoted companies, and select those which Oakley Capital Management Limited (the "Manager") believes provide the opportunity for value appreciation. 

 

 

Key data

for the period ended 30 September 2013

 

30/09/13

 

(unaudited)

Net Asset Value ("NAV")

£13,702,875

Shares in issue

14,072,002

NAV per share

97.38p

Loss on ordinary activities before tax

£87,687

Loss per share

(0.74)p

 

 

CHAIRMAN'S STATEMENT

 

On behalf of the Board of Directors, I would like to welcome you as a shareholder of Pembroke VCT plc (the "Company") and thank you for your investment in the Company.

 

Offer for subscription

The Company's offer for subscription has raised £14.8m to date. The closing date for the offer is 31 January 2014.

 

PERFORMANCE

I am pleased to present this inaugural half-yearly report for the Company.

 

At the end of the period, we had committed a total of £5.5 million to 7 companies across 3 sectors - health and fitness, consumer brands and restaurant/cafe. Given that all of these investments have been made within the reporting period, we are carrying them at cost of £3.9 million. I am pleased to report that all the investee companies are trading in line with expectation and that the Manager's team is actively involved with the founders and managers in the development of the companies. All of the investments are more fully described in the Fund Manager's Review.

 

Total net assets at 30 September 2013 were £13.7 million, comprising cash of £9.9 million and the value of investments of £3.9 million. Net asset value per share at the period end was 97.38p, reflecting share issue expenses of 2p per share and operating losses in the period of 0.62p per share.

 

SHARE ISSUES AND FUND RAISING

 

During the period there were no issues or buybacks of Ordinary Shares.

 

Valuation Policy

Investments held by the Company have been valued in accordance with the International Private Equity and Venture Capital (IPEVC) valuation guidelines (August 2010) developed by the British Venture Capital Association and other organisations. Through these guidelines, investments are valued as defined at 'fair value'. Ordinarily, unquoted investments will be valued at cost for a limited period following the date of acquisition, being the most suitable approximation of fair value unless there is an impairment or significant accretion in value during the period. The portfolio valuations are prepared by the Manager, reviewed and approved by the Board quarterly and subject to audit annually.

 

Outlook

 

We continue to enjoy good quality deal flow and, as a consequence, it is likely that the Company will be fully invested by the time of our first year anniversary.

 

I am pleased by our portfolio of investments which we believe provide exciting opportunities for the future.

 

 

Jonathan Djanogly

Chairman

 

29 November 2013

 

If you have any questions relating to your investment please contact the company secretary on 0131 2437215 or email info@pembrokevct.com, for further information refer to the Company's website www.pembrokevct.com.

 

 

FUND MANAGER'S REVIEW

 

Performance

Performance across the portfolio companies has been encouraging and given the relative nascent nature of the investments, we believe it is appropriate to continue to value the investments at cost.

 

Portfolio Activity

In the first half of the year we have made 7 investments, committing in total £5.5m and investing £3.9m to date.

 

The company has made no realisations during the period.

 

Portfolio Overview

 

 

 

 

 

 

Andrew Wolfson

Oakley Capital Management Limited

29 November 2013

INVESTMENT PORTFOLIO

as at 30 September 2013

 

 

 

Book cost

 

Valuation

 

Fund

Company

£'000

£'000

%

LBID (UK) Trading Limited*

1,000

1,000

7.30

KX Group Holding Limited

700

700

5.11

LBID Holdings Limited*

690

690

5.03

FRV LLP

471

471

3.44

Kat Maconie Limited

320

320

2.34

Troubadour Goods Limited

290

290

2.12

Plenish Cleanse Limited

225

225

1.64

Boom Spin Limited

172

172

1.25

Total investments

3,868

3,868

28.23

Net current assets

9,835

9,835

71.77

Net assets

13,703

13,703

100.00

 

Note:

*LBID (UK) Trading and LBID Holdings Limited are the registered entities through which the Company invested in La Bottega.

 

 

PRINCIPAL RISKS AND UNCERTAINTIES

 

The Company's assets consist of equities, cash and liquid resources. Its principal risks are therefore market risk, interest rate risk, credit risk and liquidity risk. 

 

Other risks faced by the Company include:

In addition to the risks mentioned above the other key risks that the Company faces are:

1. VCT status risk

The Company is required to fulfil certain criteria in order to maintain its VCT status. Where full approval as a VCT is not maintained, this could potentially result in the loss of tax relief (i.e. Capital Gains and Income Tax relief) which have been provided to both the Company and Investors alike. The Manager continually monitors compliance with the relevant VCT regulations, and has engaged PricewaterhouseCoopers LLP to provide periodic reports to ensure our compliance.

 

2. Investment risk

The Company invests in small to medium sized businesses, as such there is an inherent degree of risk and lower liquidity than investing in larger quoted companies. The Manager performs extensive in-house due diligence on all investments, and also engages independent third party providers when the investments are of a certain size. In addition to due diligence, the Company aims to diversify its portfolio by investing in a range of industries and companies at varying stages of development.

 

3. Share value risk

The value of shares may fall below the original amount invested or may not fully reflect the underlying net asset value. Dividends may not be paid. Investment in the Company should be seen as a long-term investment. There is likely to be an illiquid market in the shares with investors finding it difficult to realise their investment.

 

 

GOING CONCERN

 

The Directors have assessed the future funding requirements of the Company and are of the opinion that the Company has adequate resources to fund its operations for the foreseeable future. Therefore they believe that it is appropriate to prepare the accounts on a going concern basis.

 

 

STATEMENT OF DIRECTORS' RESPONSIBILITIES

in respect of the half-yearly financial report

 

We confirm that to the best of our knowledge:

· the condensed set of financial statements has been prepared in accordance with the Statement "Half-yearly financial reports" issued by the UK Accounting Standards Board;

· the Chairman's Statement and Fund Manager's Review (constituting the interim management report) includes a true and fair review of the information required by DTR4.2.7R of the Disclosure and Transparency Rules, being an indication of important events that have occurred during the period ended 30 September 2013 and their impact on the condensed set of financial statements;

· the Statement of Principal Risks and Uncertainties on page • is a fair review of the information required by DTR4.2.7R, being a description of the principal risks and uncertainties for the remaining six months of the year; and

· the financial statements include a fair review of the information required by DTR4.2.8R of the Disclosure and Transparency Rules, being related party transactions that have taken place in the period ended 30 September 2013 and that have materially affected the financial position or performance of the entity during that period.

 

For and on behalf of the Board

 

 

Jonathan Djanogly

Chairman

29 November 2013

 

 

INCOME STATEMENT

for the period ended 30 September 2013

 

 

Period ended

 

 

30 September 2013

 

 

(unaudited)

 

 

Revenue

Capital

 Total

 

Note

£'000

£'000

£'000

Realised/unrealised movements on investments

 

-

-

-

Income

 

40

-

40

Investment management fee

 

(13)

(38)

(51)

Other expenses

 

(77)

-

(77)

(Loss) on ordinary activities before taxation

 

(50)

(38)

(88)

Taxation on ordinary activities

 

-

-

-

(Loss) on ordinary activities after taxation

 

(50)

(38)

(88)

(Loss) per Ordinary share

2

(0.42)p

(0.32)p

(0.74)p

The total column is the profit and loss account of the Company, with the revenue and capital columns representing supplementary information under the Statement of Recommended Practice, "Financial Statements of Investment Trust Companies and Venture Capital Trusts" ("SORP") revised in January 2009.

All the items above derive from continuing operations of the Company. There were no other recognised gains or losses in the period.

 

The accompanying notes are an integral part of the statement.

 

 

CONDENSED BALANCE SHEET

as at 30 September 2013

 

 

30 September 2013

 

 

(unaudited)

 

Note

£'000

Fixed assets

 

 

Investments held at fair value

 

3,868

 

 

 

Current assets

 

 

Debtors

 

53

Cash at bank

 

9,898

Total current assets

 

9,951

 

 

 

Current liabilities

 

 

Creditors: amounts falling due within one year

 

(116)

Net current assets

 

9,835

Total assets less current liabilities

 

13,703

 

 

 

Capital and reserves

 

 

Called up share capital

 

141

Share premium account

 

13,650

Revenue reserves

 

(88)

Equity shareholders' funds

 

13,703

Net asset value per share

3

97.38p

 

The accompanying notes are an integral part of the balance sheet.

 

 

RECONCILIATION OF MOVEMENTS IN SHAREHOLDERS' FUNDS

for the period ended 30 September 2013

 

 

 

 

Period ended

 

 

30 September 2013

 

 

 

(unaudited)

 

Share

capital

Share

premium

Revenue

reserves

 

Total

 

£'000

£'000

£'000

£'000

Opening shareholders' funds

-

-

-

-

(Loss) for the period

-

-

(88)

(88)

Issue of shares

141

13,650

-

13,791

Closing shareholders' funds

141

13,650

(88)

13,703

 

The accompanying notes are an integral part of the statement.

 

 

CASH FLOW STATEMENT

for the period ended 30 September 2013

Period

ended

30 September 2013 

(unaudited)

Note

£'000

Operating activities

(Loss) on ordinary activities before taxation

 

(88)

(Increase) in debtors

 

(53)

Increase in trade creditors and accruals

 

66

Net cash outflow from operating activities

 

(75)

Taxation

 

 

Taxation paid

 

-

Financial investment

 

 

Purchase of investments

 

(3,868)

Disposal of investments

 

-

Net cash outflow from financial investment

 

(3,868)

Net cash outflow before financing

 

(3,943)

 

 

 

Financing

 

 

Issue of shares

 

14,122

Expenses of the issue of shares

 

(281)

Net cash inflow/(outflow) from financing

 

13,841

Increase/(decrease) in cash

 

9,898

 

 

 

Reconciliation of net cash flow to movement in net cash

 

 

Net cash at start of period

 

-

Net cash at end of period

 

9,898

Increase in cash during the period

 

9,898

 

The accompanying notes are an integral part of the statement.

 

 

NOTES TO THE FINANCIAL STATEMENTS

for the period ended 30 September 2013

 

1. The unaudited interim financial statements have been prepared in accordance with applicable Accounting Standards and with the Statement of Recommended Practice, "Financial Statements of Investment Trust Companies and Venture Capital Trusts" ("SORP") revised in January 2009.

 

The accounting policies applied are consistent with those intended to be applied in the first set of annual financial statements and have been consistently applied throughout the period. Full details of accounting policies will be disclosed in the annual financial statements.

 

2. The (loss) per share is based on the loss attributable to shareholders for the period and the weighted average number of shares in issue during the period of 11,770,530.

 

3. The net asset value per share at 30 September 2013 is based on net assets of £13,702,875 and the number of shares in issue of 14,072,002.

 

4. The financial information set out in this report has not been audited and does not comprise full financial statements within the meaning of Section 434 of the Companies Act 2006. Statutory accounts will be prepared and audited for the Company's first accounting reference period ending 31 March 2014.

 

5. Related Party Transactions

The Company retains Oakley Capital Management Limited ("OCML") as its Manager.

 

Peter Dubens, a non-executive director of the Company, is a director and sole shareholder of OCML. During the period ended 30 September 2013 £50,809 was payable to OCML. At the period end OCML owed the Company £7,578.

 

On 27 November 2012 50,000 redeemable preference shares in the Company were allotted and issued to OCML at a cost of £50,000. On 13 July 2013 the redeemable preference shares were fully redeemed and subsequently cancelled. £50,000 is included in creditors in respect of the funds repayable to OCML.

 

Palmer Capital LLP, of which Peter Dubens is a member, acted as promoter for the Share offer during the period. The fees in the period amounted to £281,440 out of which Palmer Capital LLP paid the costs of the Share offer.

 

The number of ordinary shares (all of which are held beneficially) by the directors and certain members of the management team of OCML are:

30 September 2013

shares held

Jonathan Djanogly

Director

25,000

Laurence Blackall

Director

200,000

Peter Dubens

Director

400,000

Kathy Jackson

Manager

60,000

Stewart Porter

Manager

75,000

Save as disclosed in this paragraph there is no conflict of interest between the Company, the duties of the directors, the duties of the directors of the Manager and their private interests and other duties.

 

6. Copies of the half-yearly report are being sent to all shareholders. Further copies are available free of charge from The City Partnership (UK) Limited, secretary to the Company by telephoning 0131 243 7215.

 

 

CORPORATE INFORMATION

 

Directors

Registrar

Jonathan Simon Djanogly

The City Partnership (UK) Limited

Laurence Charles Neil Blackall

c/o Share Registrars

Peter Adam Daiches Dubens

Suite E, First Floor

9 Lion and Lamb Yard

all of:

Farnham

3 Cadogan Gate

Surrey

London

GU9 7LL

SW1X 0AS

Auditors

Grant Thornton UK LLP

Secretary

Grant Thornton House

The City Partnership (UK) Limited

Melton Street

Thistle House

Euston Square, London

21 Thistle Street

NW1 2EP

Edinburgh

EH2 1DF

Solicitors

Telephone: 01312437215

Howard KennedyFsi LLP

19 Cavendish Square

London

Manager

W1A 2AW

Oakley Capital Management Limited

3 Cadogan Gate

Bankers

London

Barclays Bank plc

SW1X 0AS

1st Floor

99 Hatton Gardens

VCT Tax Adviser

London

PricewaterhouseCoopers LLP

EC1N 8DN

1 Embankment Place

London

WC2N 6RH

 

SHAREHOLDER INFORMATION

 

Share price

The Company's shares are listed on the London Stock Exchange.

 

Financial calendar

November 2013 Half-yearly report for the period ended 30 September 2013 published

February 2014 Interim management statement released

31 March 2014 Year end

June 2014 Announcement of final results for the year ended 31 March 2014

August 2014 Annual General Meeting

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR LLFLILFLAFIV
Date   Source Headline
26th Aug 20201:35 pmRNSResult of Conversion of Shares
26th Aug 20207:30 amRNSSuspension of listing of ordinary shares
14th Aug 202011:46 amRNSResults of General and Ord Share class Meetings
4th Aug 20209:14 amRNSIntention to launch an offer for subscription
24th Jul 20203:39 pmRNSDividend Declaration
24th Jul 20203:38 pmRNSAnnual Financial Report
16th Jul 20202:57 pmRNSCirc re. Amendment to Articles
1st May 20209:29 amRNSTotal Voting Rights
14th Apr 202012:01 pmRNSIssue of Equity
6th Apr 20201:42 pmRNSIssue of Equity
3rd Apr 20205:13 pmRNSOffer for subscription closing date
1st Apr 20207:51 amRNSTotal Voting Rights
20th Mar 20204:59 pmRNSIssue of Equity
19th Mar 20201:58 pmRNSNet Asset Value(s)
2nd Mar 20204:20 pmRNSIssue of Equity
27th Feb 202011:28 amRNSOffer for subscription - over allotment facility
3rd Feb 202011:00 amRNSTotal Voting Rights
21st Jan 20203:35 pmRNSIssue of Equity
15th Jan 20205:13 pmRNSOffer for Subscription - over-allotment facility
18th Dec 20198:19 amRNSIssue of Equity
16th Dec 20194:15 pmRNSHolding(s) in Company
13th Dec 20193:21 pmRNSHalf-year Report
2nd Dec 20194:24 pmRNSTotal Voting Rights
8th Nov 20195:09 pmRNSIssue of Equity
31st Oct 20194:08 pmRNSIssue of Equity
16th Oct 20194:07 pmRNSOffer for subscription update
1st Oct 20194:22 pmRNSDirector/PDMR Shareholding
30th Sep 20195:33 pmRNSIssue of Equity
27th Sep 20198:16 amRNSResult of GM
27th Sep 20198:15 amRNSResult of AGM
23rd Sep 20194:36 pmRNSRelated party transaction
2nd Sep 20191:28 pmRNSPublication of Prospectus and Circular
1st Aug 201910:35 amRNSTotal Voting Rights
29th Jul 20195:17 pmRNSDividend Declaration
29th Jul 20195:15 pmRNSAnnual Financial Report
16th Jul 20199:39 amRNSIntention to launch an offer for subscription
5th Jul 20191:08 pmRNSIssue of Equity
4th Jun 20199:15 amRNSOffer for subscription closing date
3rd Jun 20191:19 pmRNSTotal Voting Rights
16th May 20194:39 pmRNSIssue of Equity
1st May 201912:18 pmRNSTotal Voting Rights
15th Apr 20192:40 pmRNSIssue of Equity - replacement
8th Apr 20194:08 pmRNSIssue of Equity
5th Apr 20197:59 amRNSOffer for subscription over allotment facility
2nd Apr 20193:04 pmRNSIssue of Equity
29th Mar 20194:20 pmRNSTransaction in Own Shares
1st Mar 20198:45 amRNSTotal Voting Rights
22nd Feb 201911:25 amRNSIssue of Equity
14th Dec 201811:42 amRNSHalf-year Report
13th Dec 20182:23 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.